MedPath

Moscow Clinical Scientific Center

🇷🇺Russia
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

13

Active:0
Completed:4

Trial Phases

3 Phases

Phase 2:1
Phase 3:1
Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (66.7%)
Phase 2
1 (16.7%)
Phase 3
1 (16.7%)

Local Cecal Cancer - Optimization of Surgical Treatment

Not Applicable
Recruiting
Conditions
Cecal Neoplasms
Colonic Neoplasms Malignant
First Posted Date
2023-11-07
Last Posted Date
2023-11-18
Lead Sponsor
Moscow Clinical Scientific Center
Target Recruit Count
200
Registration Number
NCT06121089
Locations
🇷🇺

Moscow Clinical Scientific Center, Moscow, Russian Federation

Epidemiology of Helicobacter Pylori Infection in Moscow

Recruiting
Conditions
Gastric Cancer
Gastric Atrophy
Helicobacter Pylori Infection
First Posted Date
2023-03-20
Last Posted Date
2023-03-20
Lead Sponsor
Moscow Clinical Scientific Center
Target Recruit Count
5121
Registration Number
NCT05775120
Locations
🇷🇺

A.S. Loginov Moscow Clinical Scientific Center, Moscow, Russian Federation

Pancreatic Fibrosis as a Prognostic Factor

Recruiting
Conditions
Pancreatic Fibrosis
First Posted Date
2023-03-20
Last Posted Date
2023-03-20
Lead Sponsor
Moscow Clinical Scientific Center
Target Recruit Count
150
Registration Number
NCT05775107
Locations
🇷🇺

A.S. Loginov Moscow Clinical Scientific Center, Moscow, Russian Federation

Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

Recruiting
Conditions
Pancreas Cancer
Breast Cancer
Interventions
First Posted Date
2022-10-14
Last Posted Date
2022-10-14
Lead Sponsor
Moscow Clinical Scientific Center
Target Recruit Count
35
Registration Number
NCT05580887
Locations
🇷🇺

Moscow Clinical Scientific Center named after AS Loginov, Moscow, Not Required, Russian Federation

A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations

Conditions
Solid Tumor
Gynecological Malignancies
Myelosuppression
High-Risk Cancer
Gastrointestinal Cancer
Breast Cancer
Interventions
First Posted Date
2021-05-27
Last Posted Date
2021-06-02
Lead Sponsor
Moscow Clinical Scientific Center
Target Recruit Count
285
Registration Number
NCT04905329
Locations
🇷🇺

Moscow Clinical Scientific Center named after AS Loginov, Moscow, Not Required, Russian Federation

🇷🇺

FSBI NMITs oncology named after N.N. Blokhin, the Ministry of Health of Russia, Moscow, Not Required, Russian Federation

🇷🇺

FSBI "National medical research center for obstetrics, gynecology and perinatology named after academician VI Kulakov" Ministry of healthcare of the Russian Federation, Moscow, Russian Federation

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.